Zobrazeno 1 - 10
of 292
pro vyhledávání: '"Athos Bousvaros"'
Autor:
Nathan P Palmer, Jocelyn A Silvester, Jessica J Lee, Andrew L Beam, Inbar Fried, Vladimir I Valtchinov, Fedik Rahimov, Sek Won Kong, Saum Ghodoussipour, Helen C Hood, Athos Bousvaros, Richard J Grand, Louis M Kunkel, Isaac S Kohane
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0222952 (2019)
BackgroundPresenting features of inflammatory bowel disease (IBD) are non-specific. We hypothesized that mRNA profiles could (1) identify genes and pathways involved in disease pathogenesis; (2) identify a molecular signature that differentiates IBD
Externí odkaz:
https://doaj.org/article/9fb54ecdb5224005bb2588996be46f10
Autor:
Sigrid Bairdain, Moti Freiman, Jeanette M P and eacute;rez-Rossell and oacute;, Michael J Callahan, Athos Bousvaros, Simon K Warfield, Bradley C Linden
Publikováno v:
Archives of Clinical and Experimental Surgery, Vol 5, Iss 2, Pp 116-120 (2016)
Crohn disease is a chronic inflammatory bowel disease of unknown etiology with approximately one-third of patients being children and adolescents. Long-standing inflammation can result in fibrostenosing disease, usually of the terminal ileum. However
Externí odkaz:
https://doaj.org/article/4c107b2c3c9748c4911dc4bee7d4113a
Autor:
Naamah L Zitomersky, Benjamin J Atkinson, Sarah W Franklin, Paul D Mitchell, Scott B Snapper, Laurie E Comstock, Athos Bousvaros
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e63686 (2013)
There is extensive evidence implicating the intestinal microbiota in inflammatory bowel disease [IBD], but no microbial agent has been identified as a sole causative agent. Bacteroidales are numerically dominant intestinal organisms that associate wi
Externí odkaz:
https://doaj.org/article/dd7c33b2592d446091bd9be0c53ad9f8
Autor:
Eliseo Papa, Michael Docktor, Christopher Smillie, Sarah Weber, Sarah P Preheim, Dirk Gevers, Georgia Giannoukos, Dawn Ciulla, Diana Tabbaa, Jay Ingram, David B Schauer, Doyle V Ward, Joshua R Korzenik, Ramnik J Xavier, Athos Bousvaros, Eric J Alm
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39242 (2012)
BACKGROUND:Pediatric inflammatory bowel disease (IBD) is challenging to diagnose because of the non-specificity of symptoms; an unequivocal diagnosis can only be made using colonoscopy, which clinicians are reluctant to recommend for children. Diagno
Externí odkaz:
https://doaj.org/article/dbee976b36a54737ac2c5bf0d90ea952
Autor:
Stacy A. Kahn, Athos Bousvaros
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 76:407-409
Autor:
Lori A Zimmerman, Jonathan Spaan, Nathan Weinbren, Krishanth Manokaran, Aravindh Ajithkumar, Anna Bogursky, Enju Liu, Craig Lillehei, Brent R Weil, Jill M Zalieckas, Athos Bousvaros, Paul A Rufo
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition.
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease
Autor:
Arthur J, Kastl, Kimberly N, Weaver, Xian, Zhang, Jennifer A, Strople, Jeremy, Adler, Marla C, Dubinsky, Athos, Bousvaros, Runa, Watkins, Xiangfeng, Dai, Wenli, Chen, Raymond K, Cross, Peter D R, Higgins, Ryan C, Ungaro, Meenakshi, Bewtra, Emanuelle A, Bellaguarda, Francis A, Farraye, Kelly Y, Chun, Michael, Zikry, Manory, Fernando, Monique, Bastidas, Cristian G, Hernandez, Riley G, Craig, Margie E, Boccieri, Anne, Firestine, Millie D, Long, Michael D, Kappelman
Publikováno v:
American Journal of Gastroenterology. 118:129-137
Children with inflammatory bowel disease (IBD) may respond differently to COVID-19 immunization as compared with healthy children or adults with IBD. Those younger than 12 years receive a lower vaccine dose than adults. We sought to describe the safe
Autor:
Stacy A, Kahn, Athos, Bousvaros
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 75:418-422
Increasingly, in the United States, the prescribing of high-cost drugs has become a challenge for physicians and other practitioners. Such drugs are highly regulated by third-party payers (aka insurance), as well as pharmacy benefit managers. Not inf
Autor:
Jessica R. Allegretti, Vanessa Mitsialis, James B. Canavan, Scott B. Snapper, Matthew Hamilton, Jared Barends, Madeline Carrellas, Katherine Freer, Jordan Gringauz, Julia Green, Noah Herwood, Jonathan Hurtado, Ryan Kelly, Jennifer Mitri, Caroline Rourke, Gwen Saccocia, Sydney Whitcomb, Enju Liu, David Klatzmann, Punyanganie de Silva, Frank A. Farraye, Joseph D. Feuerstein, Alan Moss, Samir A. Shah, Joshua R. Korzenik, Athos Bousvaros, John Koreth, Robert Soiffer, Jerome Ritz, Tanya Logvinenko, Ashwin Ananthakrishnan, Hans Herfath
Publikováno v:
Gastroenterology.
Autor:
Yanjia Jason Zhang, Athos Bousvaros, Michael Docktor, Abby Kaplan, Paul A. Rufo, McKenzie Leier, Madison Weatherly, Lori Zimmerman, Le Thanh Tu Nguyen, Brenda Barton, George Russell, Eric J. Alm, Stacy A. Kahn
Publikováno v:
medRxiv
BackgroundFecal Microbiota Transplant (FMT) has proven effective in treating recurrentClostridioides difficileinfection (rCDI) and has shown some success in treating inflammatory bowel diseases (IBD). There is emerging evidence that host engraftment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79af43eba8c6d5413c09c7788ddaea01
https://europepmc.org/articles/PMC9915819/
https://europepmc.org/articles/PMC9915819/